StockData

Encompass Health vs Ensign

EHC and ENSG side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How EHC and ENSG compare

Encompass Health is the larger company, worth 1.3 times as much as Ensign ($14.0B against $11.0B).

On earnings, Encompass Health is cheaper: it trades at 23.1× trailing earnings, against 28.0× for Ensign.

Ensign grew revenue faster over the last twelve months (17.5% versus 9.5% for Encompass Health).

Encompass Health keeps more of each dollar of sales as profit, with a net margin of 10.0% compared with 7.0% at Ensign.

Both pay dividends: Encompass Health yields 0.55% and Ensign 0.14%.

Ensign scores higher on the StockData Score (20 against 16 for Encompass Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricEHCENSG
Size and price
Market cap$14.0B$11.0B
Share price$142.11$188.23
Change, 1 year24.4%6.2%
Change, 5 years132%142%
Beta (5Y)0.55−0.23
Employees42K46K
StockData Score
Total score1620 (better)
Valuation score1 (better)0
Growth score46 (better)
Performance score56 (better)
Health score35 (better)
Dividend score33
Valuation
P/E23.1× (better)28.0×
P/S2.3×1.9× (better)
P/B5.4×4.3× (better)
EV/EBITDA11.6× (better)17.1×
P/FCF33.9×–
PEG0.85 (better)2.01
FCF yield2.9%–
Fair value$128.88$161.27
Margin of safety−10.3% (better)−16.7%
Growth
Revenue growth (TTM)9.5%17.5% (better)
Revenue growth, 5Y average10.7%16.1% (better)
Net income growth (TTM)18.8%21.6% (better)
EPS growth (TTM)20.2%20.2% (better)
EPS growth, 5Y average14.2% (better)13.8%
Profitability
Gross margin–21.2%
Operating margin–9.0%
Net margin10.0% (better)7.0%
FCF margin6.7%–
Return on equity25.5% (better)17.1%
Return on invested capital–18.5%
Financial health
Debt / equity1.010.08 (better)
Net debt / EBITDA1.68 (better)−0.31
Interest coverage–62.8×
Current ratio1.191.20 (better)
Altman Z-score2.963.66 (better)
Piotroski F-score8 (better)6
Dividends and buybacks
Dividend yield0.55% (better)0.14%
Payout ratio12.1%3.8%
Years of dividend growth215 (better)
Dividend growth, 5Y average−8.5%4.5% (better)
Buyback yield1.8% (better)0.43%
Shareholder yield2.3% (better)0.57%
Ownership
Held by institutions97.0%90.5%
Held by insiders1.0%3.6%
Insider net buying, 12 months−$47.8M−$6.0M (better)
Short interest, % of float3.7%2.6%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.